Rafael Holdings, Inc. (RFL) stock
RFLNYSEPharmaceutical PreparationsFiscal year ends July 31
$0.99+0.07 (+8.07%)
Close on Nov 18, 2026Market cap $51.51MP/E –Yield –
Rafael operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Rafael's operating income for the twelve months ending Jul 31, 2026 was -$33.41M. For fiscal 2026 it was -$33.41M. The highest annual figure on record is $1.19M in fiscal 2016.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jul 31, 2026 | -$33.41M | – |
| FY2025 | Jul 31, 2025 | -$29.16M | – |
| FY2024 | Jul 31, 2024 | -$102.63M | – |
| FY2023 | Jul 31, 2023 | -$15.04M | – |
| FY2022 | Jul 31, 2022 | -$60.48M | – |
| FY2021 | Jul 31, 2021 | -$28.20M | – |
| FY2020 | Jul 31, 2020 | -$8.47M | – |
| FY2019 | Jul 31, 2019 | -$6.70M | – |
| FY2018 | Jul 31, 2018 | -$3.84M | -1838.0% |
| FY2017 | Jul 31, 2017 | $221.00K | -81.5% |
| FY2016 | Jul 31, 2016 | $1.19M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jul 31, 2026 | -$9.73M | – |
| Q3 FY2026CQ1 2026 | Apr 30, 2026 | -$6.87M | – |
| Q2 FY2026CQ4 2025 | Jan 31, 2026 | -$6.66M | – |
| Q1 FY2026CQ3 2025 | Oct 31, 2025 | -$10.14M | – |
| Q4 FY2025CQ2 2025 | Jul 31, 2025 | -$12.76M | – |
| Q3 FY2025CQ1 2025 | Apr 30, 2025 | -$5.91M | – |
| Q2 FY2025CQ4 2024 | Jan 31, 2025 | -$6.64M | – |
| Q1 FY2025CQ3 2024 | Oct 31, 2024 | -$3.84M | – |
| Q4 FY2024CQ2 2024 | Jul 31, 2024 | -$3.85M | – |
| Q3 FY2024CQ1 2024 | Apr 30, 2024 | -$93.16M | – |
| Q2 FY2024CQ4 2023 | Jan 31, 2024 | -$3.14M | – |
| Q1 FY2024CQ3 2023 | Oct 31, 2023 | -$2.48M | – |
| Q4 FY2023CQ2 2023 | Jul 31, 2023 | -$2.61M | – |
| Q3 FY2023CQ1 2023 | Apr 30, 2023 | -$3.03M | – |
| Q2 FY2023CQ4 2022 | Jan 31, 2023 | -$4.26M | – |
| Q1 FY2023CQ3 2022 | Oct 31, 2022 | -$5.14M | – |
| Q4 FY2022CQ2 2022 | Jul 31, 2022 | -$4.84M | – |
| Q3 FY2022CQ1 2022 | Apr 30, 2022 | -$4.69M | – |
| Q2 FY2022CQ4 2021 | Jan 31, 2022 | -$1.60M | – |
| Q1 FY2022CQ3 2021 | Oct 31, 2021 | -$49.54M | – |
| Q4 FY2021CQ2 2021 | Jul 31, 2021 | -$11.41M | – |
| Q3 FY2021CQ1 2021 | Apr 30, 2021 | -$3.48M | – |
| Q2 FY2021CQ4 2020 | Jan 31, 2021 | -$10.82M | – |
| Q1 FY2021CQ3 2020 | Oct 31, 2020 | -$2.49M | – |
| Q4 FY2020CQ2 2020 | Jul 31, 2020 | -$3.05M | – |
| Q3 FY2020CQ1 2020 | Apr 30, 2020 | -$1.97M | – |
| Q2 FY2020CQ4 2019 | Jan 31, 2020 | -$1.91M | – |
| Q1 FY2020CQ3 2019 | Oct 31, 2019 | -$1.54M | – |
| Q4 FY2019CQ2 2019 | Jul 31, 2019 | -$2.75M | – |
| Q3 FY2019CQ1 2019 | Apr 30, 2019 | -$1.42M | – |
| Q2 FY2019CQ4 2018 | Jan 31, 2019 | -$1.41M | – |
| Q1 FY2019CQ3 2018 | Oct 31, 2018 | -$1.12M | – |
| Q4 FY2018CQ2 2018 | Jul 31, 2018 | -$1.24M | -1341.0% |
| Q3 FY2018CQ1 2018 | Apr 30, 2018 | -$731.00K | – |
| Q2 FY2018CQ4 2017 | Jan 31, 2018 | -$816.00K | -742.5% |
| Q1 FY2018CQ3 2017 | Oct 31, 2017 | -$1.06M | – |
| Q4 FY2017CQ2 2017 | Jul 31, 2017 | $100.00K | – |
| Q3 FY2017CQ1 2017 | Apr 30, 2017 | -$164.00K | – |
| Q2 FY2017CQ4 2016 | Jan 31, 2017 | $127.00K | – |
See a number that looks wrong?